Multicenter COMPACT study of COMplications in Patients with sickle cell disease and utilization of iron Chelation Therapy

Lanetta B Jordan, Patricia Adams-Graves, Julie Kanter-Washko, Patricia A. Oneal, Medha Sasane, Francis Vekeman, Christine Bieri, Matthew Magestro, Andrea Marcellari, Mei Sheng Duh

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Over the past few decades, lifespans of sickle cell disease (SCD) patients have increased; hence, they encounter multiple complications. Early detection, appropriate comprehensive care, and treatment may prevent or delay onset of complications. Objective: We collected longitudinal data on sickle cell disease (SCD) complication rates and associated resource utilization relative to blood transfusion patterns and iron chelation therapy (ICT) use in patients aged 16 years to address a gap in the literature. Research design and methods: Medical records of 254 SCD patients 16 years were retrospectively reviewed at three US tertiary care centers. Main outcome measures: We classified patients into cohorts based on cumulative units of blood transfused and ICT history: <15 units, no ICT (Cohort 1 [C1]), 15 units, no ICT (Cohort 2 [C2]), and 15 units with ICT (Cohort 3 [C3]). We report SCD complication rates per patient per year; cohort comparisons use rate ratios (RRs). Results: Cohorts had 69 (C1), 91 (C2), and 94 (C3) patients. Pain led to most hospitalizations (76%) and emergency department (ED) (82%) visits. Among transfused patients (C2+C3), those receiving ICT were less likely to experience SCD complications than those who did not (RR [95% CI] C2 vs. C3: 1.33 [1.25-1.42]). Similar trends (RR [95% CI]) were observed in ED visits and hospitalizations associated with SCD complications (C2 vs. C3, ED: 1.94 [1.70-2.21]; hospitalizations: 1.61 [1.45-1.78]), but not in outpatient visits. Conclusions: Although the most commonly reported SCD complication among all patients was pain, patients who received ICT were less likely to experience pain and other complications than those who did not. These results highlight the need for increased patient and provider education on the importance of comprehensive disease management.

Original languageEnglish (US)
Pages (from-to)513-523
Number of pages11
JournalCurrent Medical Research and Opinion
Volume31
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Chelation Therapy
Sickle Cell Anemia
Multicenter Studies
Iron
Hospital Emergency Service
Hospitalization
Pain
Patient Education
Disease Management
Tertiary Care Centers
Blood Transfusion
Medical Records
Research Design
Outpatients
History
Outcome Assessment (Health Care)

Keywords

  • Blood transfusions
  • Complications
  • Iron chelation therapy
  • Iron overload
  • Sickle cell disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jordan, L. B., Adams-Graves, P., Kanter-Washko, J., Oneal, P. A., Sasane, M., Vekeman, F., ... Duh, M. S. (2015). Multicenter COMPACT study of COMplications in Patients with sickle cell disease and utilization of iron Chelation Therapy. Current Medical Research and Opinion, 31(3), 513-523. https://doi.org/10.1185/03007995.2014.998815

Multicenter COMPACT study of COMplications in Patients with sickle cell disease and utilization of iron Chelation Therapy. / Jordan, Lanetta B; Adams-Graves, Patricia; Kanter-Washko, Julie; Oneal, Patricia A.; Sasane, Medha; Vekeman, Francis; Bieri, Christine; Magestro, Matthew; Marcellari, Andrea; Duh, Mei Sheng.

In: Current Medical Research and Opinion, Vol. 31, No. 3, 01.03.2015, p. 513-523.

Research output: Contribution to journalArticle

Jordan, LB, Adams-Graves, P, Kanter-Washko, J, Oneal, PA, Sasane, M, Vekeman, F, Bieri, C, Magestro, M, Marcellari, A & Duh, MS 2015, 'Multicenter COMPACT study of COMplications in Patients with sickle cell disease and utilization of iron Chelation Therapy', Current Medical Research and Opinion, vol. 31, no. 3, pp. 513-523. https://doi.org/10.1185/03007995.2014.998815
Jordan, Lanetta B ; Adams-Graves, Patricia ; Kanter-Washko, Julie ; Oneal, Patricia A. ; Sasane, Medha ; Vekeman, Francis ; Bieri, Christine ; Magestro, Matthew ; Marcellari, Andrea ; Duh, Mei Sheng. / Multicenter COMPACT study of COMplications in Patients with sickle cell disease and utilization of iron Chelation Therapy. In: Current Medical Research and Opinion. 2015 ; Vol. 31, No. 3. pp. 513-523.
@article{8ddecf8b796845f6811b71605564b5ed,
title = "Multicenter COMPACT study of COMplications in Patients with sickle cell disease and utilization of iron Chelation Therapy",
abstract = "Background: Over the past few decades, lifespans of sickle cell disease (SCD) patients have increased; hence, they encounter multiple complications. Early detection, appropriate comprehensive care, and treatment may prevent or delay onset of complications. Objective: We collected longitudinal data on sickle cell disease (SCD) complication rates and associated resource utilization relative to blood transfusion patterns and iron chelation therapy (ICT) use in patients aged 16 years to address a gap in the literature. Research design and methods: Medical records of 254 SCD patients 16 years were retrospectively reviewed at three US tertiary care centers. Main outcome measures: We classified patients into cohorts based on cumulative units of blood transfused and ICT history: <15 units, no ICT (Cohort 1 [C1]), 15 units, no ICT (Cohort 2 [C2]), and 15 units with ICT (Cohort 3 [C3]). We report SCD complication rates per patient per year; cohort comparisons use rate ratios (RRs). Results: Cohorts had 69 (C1), 91 (C2), and 94 (C3) patients. Pain led to most hospitalizations (76{\%}) and emergency department (ED) (82{\%}) visits. Among transfused patients (C2+C3), those receiving ICT were less likely to experience SCD complications than those who did not (RR [95{\%} CI] C2 vs. C3: 1.33 [1.25-1.42]). Similar trends (RR [95{\%} CI]) were observed in ED visits and hospitalizations associated with SCD complications (C2 vs. C3, ED: 1.94 [1.70-2.21]; hospitalizations: 1.61 [1.45-1.78]), but not in outpatient visits. Conclusions: Although the most commonly reported SCD complication among all patients was pain, patients who received ICT were less likely to experience pain and other complications than those who did not. These results highlight the need for increased patient and provider education on the importance of comprehensive disease management.",
keywords = "Blood transfusions, Complications, Iron chelation therapy, Iron overload, Sickle cell disease",
author = "Jordan, {Lanetta B} and Patricia Adams-Graves and Julie Kanter-Washko and Oneal, {Patricia A.} and Medha Sasane and Francis Vekeman and Christine Bieri and Matthew Magestro and Andrea Marcellari and Duh, {Mei Sheng}",
year = "2015",
month = "3",
day = "1",
doi = "10.1185/03007995.2014.998815",
language = "English (US)",
volume = "31",
pages = "513--523",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Multicenter COMPACT study of COMplications in Patients with sickle cell disease and utilization of iron Chelation Therapy

AU - Jordan, Lanetta B

AU - Adams-Graves, Patricia

AU - Kanter-Washko, Julie

AU - Oneal, Patricia A.

AU - Sasane, Medha

AU - Vekeman, Francis

AU - Bieri, Christine

AU - Magestro, Matthew

AU - Marcellari, Andrea

AU - Duh, Mei Sheng

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Background: Over the past few decades, lifespans of sickle cell disease (SCD) patients have increased; hence, they encounter multiple complications. Early detection, appropriate comprehensive care, and treatment may prevent or delay onset of complications. Objective: We collected longitudinal data on sickle cell disease (SCD) complication rates and associated resource utilization relative to blood transfusion patterns and iron chelation therapy (ICT) use in patients aged 16 years to address a gap in the literature. Research design and methods: Medical records of 254 SCD patients 16 years were retrospectively reviewed at three US tertiary care centers. Main outcome measures: We classified patients into cohorts based on cumulative units of blood transfused and ICT history: <15 units, no ICT (Cohort 1 [C1]), 15 units, no ICT (Cohort 2 [C2]), and 15 units with ICT (Cohort 3 [C3]). We report SCD complication rates per patient per year; cohort comparisons use rate ratios (RRs). Results: Cohorts had 69 (C1), 91 (C2), and 94 (C3) patients. Pain led to most hospitalizations (76%) and emergency department (ED) (82%) visits. Among transfused patients (C2+C3), those receiving ICT were less likely to experience SCD complications than those who did not (RR [95% CI] C2 vs. C3: 1.33 [1.25-1.42]). Similar trends (RR [95% CI]) were observed in ED visits and hospitalizations associated with SCD complications (C2 vs. C3, ED: 1.94 [1.70-2.21]; hospitalizations: 1.61 [1.45-1.78]), but not in outpatient visits. Conclusions: Although the most commonly reported SCD complication among all patients was pain, patients who received ICT were less likely to experience pain and other complications than those who did not. These results highlight the need for increased patient and provider education on the importance of comprehensive disease management.

AB - Background: Over the past few decades, lifespans of sickle cell disease (SCD) patients have increased; hence, they encounter multiple complications. Early detection, appropriate comprehensive care, and treatment may prevent or delay onset of complications. Objective: We collected longitudinal data on sickle cell disease (SCD) complication rates and associated resource utilization relative to blood transfusion patterns and iron chelation therapy (ICT) use in patients aged 16 years to address a gap in the literature. Research design and methods: Medical records of 254 SCD patients 16 years were retrospectively reviewed at three US tertiary care centers. Main outcome measures: We classified patients into cohorts based on cumulative units of blood transfused and ICT history: <15 units, no ICT (Cohort 1 [C1]), 15 units, no ICT (Cohort 2 [C2]), and 15 units with ICT (Cohort 3 [C3]). We report SCD complication rates per patient per year; cohort comparisons use rate ratios (RRs). Results: Cohorts had 69 (C1), 91 (C2), and 94 (C3) patients. Pain led to most hospitalizations (76%) and emergency department (ED) (82%) visits. Among transfused patients (C2+C3), those receiving ICT were less likely to experience SCD complications than those who did not (RR [95% CI] C2 vs. C3: 1.33 [1.25-1.42]). Similar trends (RR [95% CI]) were observed in ED visits and hospitalizations associated with SCD complications (C2 vs. C3, ED: 1.94 [1.70-2.21]; hospitalizations: 1.61 [1.45-1.78]), but not in outpatient visits. Conclusions: Although the most commonly reported SCD complication among all patients was pain, patients who received ICT were less likely to experience pain and other complications than those who did not. These results highlight the need for increased patient and provider education on the importance of comprehensive disease management.

KW - Blood transfusions

KW - Complications

KW - Iron chelation therapy

KW - Iron overload

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=84924619556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924619556&partnerID=8YFLogxK

U2 - 10.1185/03007995.2014.998815

DO - 10.1185/03007995.2014.998815

M3 - Article

VL - 31

SP - 513

EP - 523

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 3

ER -